Viscosupplementation Market
The viscosupplementation market consists of hyaluronic acid injections used to treat pain and improve mobility in joints, primarily for knee osteoarthritis. The main customers are patients with mild to moderate osteoarthritis, particularly within the aging global population, who are seeking non-surgical treatment options. Key growth drivers include the rising prevalence of osteoarthritis, an increasing demand for minimally invasive alternatives to joint replacement surgery, and technological advancements in hyaluronic acid formulations that improve efficacy and convenience.
10.1%
Compound Annual Growth Rate
$7.07B
Estimated 2026
$15.3B
By 2034
Get full access to
this market report
Sign up to unlock detailed analysis, startup opportunities, and competitive insights for "Viscosupplementation Market".